Pharmaceuticals

Octreotide Market Forecast 2026–2030 Presenting Long-Term Industry Insights

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Octreotide Market From 2026 To 2030?

The octreotide market has experienced steady expansion in recent years. Its valuation is predicted to increase from $2.56 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.0%. The historical growth of this market is attributable to the clinical effectiveness in acromegaly treatment, a rise in the diagnosis of neuroendocrine tumors, the availability of depot formulations, the broadening of endocrine specialty care, and the adoption of hospital-based hormone therapy.

The octreotide market size is anticipated to experience consistent expansion over the upcoming years. By 2030, its valuation is projected to reach $3.26 billion, demonstrating a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the forecast period include the rising demand for long-acting injectables, a growing incidence of endocrine disorders, the broadening of oncology indications, enhanced hospital infusion capabilities, and advancements in sustained-release formulations. Key trends emerging over the forecast horizon encompass the expanded application in managing hormonal disorders, the increasing uptake of long-acting injectable formulations, broadened treatment options for neuroendocrine tumors, a surge in demand for hospital-administered treatments, and a heightened emphasis on managing symptoms in chronic ailments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21234&type=smp

What Factors Are Contributing To The Growth Of The Octreotide Market?

The escalating incidence of cancer is anticipated to drive the expansion of the octreotide market going forward. Cancer constitutes a collection of illnesses defined by the unchecked proliferation and dissemination of atypical cells within the body. The rise in cancer occurrences is primarily attributable to demographic aging, environmental influences, lifestyle decisions, and enhanced diagnostic techniques. Octreotide contributes to combating the surge in cancer rates through its ability to impede tumor development, manage hormone-related cancers, and relieve accompanying symptoms. As an illustration, reports released in May 2024 by the National Cancer Institute (NCI), a US-based government agency, indicated nearly 20 million new cancer cases and 9.7 million deaths worldwide, with forecasts for 2040 suggesting an increase to 29.9 million cases and 15.3 million deaths. Consequently, the escalating prevalence of cancer is fueling the growth of the octreotide market.

What Segment Categories Shape The Octreotide Market Segment Landscape?

The octreotide market covered in this report is segmented –

1) By Type: Octreotide Acetate, Octreotide, Octreotide Chloride, Octreotide Hydrochloride, Indium In-111 Octreotide

2) By Form: Injection, Powder, Microspheres

3) By Indications: Diarrhea, Acromegaly, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-user: Pharmaceutical, Clinical Research

Subsegments:

1) By Octreotide Acetate: Injectable Formulation, Depot Injectable Formulation

2) By Octreotide: Injectable Formulation, Oral Formulation

3) By Octreotide Chloride: Injectable Formulation, Lyophilized Powder

4) By Octreotide Hydrochloride: Injectable Formulation, Lyophilized Powder

5) By Indium In-111 Octreotide: Diagnostic Radiopharmaceutical Formulation, Therapeutic Radiopharmaceutical Formulation

Which Trends Are Impacting The Progress Of The Octreotide Market?

Major companies within the octreotide market are focusing on developing innovative products, such as injectable suspensions, to enhance patient adherence and convenience. These injectable suspensions are fast-acting medications administered via injection, which allows for quicker absorption into the bloodstream and bypasses the digestive system for a faster onset of action. For instance, in October 2024, Teva Pharmaceuticals, an Israel-based pharmaceutical company, launched the generic version of Sandostatin LAR Depot (octreotide acetate for injectable suspension), designed for rapid absorption into the bloodstream upon injection. Octreotide, a synthetic analog of the natural hormone somatostatin, is primarily utilized to treat conditions like acromegaly, carcinoid syndrome, and VIP-secreting tumors. This injectable delivery method offers a quicker onset of action compared to traditional oral tablets, thereby making it easier for patients to adhere to their treatment plans.

Who Are The Companies Operating Across The Octreotide Market Value Chain?

Major companies operating in the octreotide market are Novartis International AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Ipsen S.A., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Bachem Holding AG, Chemi S.p.A., LGM Pharma LLC, Hainan Shuangcheng Pharmaceuticals Co. Ltd., USV Private Limited, ChemWerth Inc., Shanghai Soho-Yiming Pharmaceuticals Co. Ltd., Neiss Labs Private Limited, Samarth Life Sciences Private Limited, TAPI Technology & API Services, BCN Peptides S.A.

Get The Full Octreotide Market Report:

https://www.thebusinessresearchcompany.com/report/octreotide-global-market-report

Which Region Dominates The Octreotide Market By Market Share?

North America was the largest region in the octreotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the octreotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Octreotide Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/octreotide-global-market-report

Browse Through More Reports Similar to the Global Octreotide Market 2026, By The Business Research Company

Oligonucleotide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Octadecanedioic Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/octadecanedioic-acid-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795